Latest news
ABLi reports biomarker findings from risvodetinib study for Parkinson’s - Clinical Trials ArenaClinical Trials Arena · Wed, 05 Aug 2026 10:22:34 GMTABLi Therapeutics Announces Outcomes from its Parkinson’s-related Biomarker Study Demonstrating Modification of Human Disease with Risvodetinib - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:05:00 GMTABLI ABKI Changes to the Board Model Risk Sub-Committee - MoneywebMoneyweb · Thu, 30 Jul 2026 14:30:00 GMT